Skip to main content

Table 3 Early Surgical outcomes

From: Safety and feasibility of neoadjuvant chemotherapy as a surgical bridge for acute left-sided malignant colorectal obstruction: a retrospective study

 

Surgery* (n = 63)

Neoadjuvant chemotherapy*(n = 32)

P value

Postoperative CEA, N%

0.692

 Normal

33 (63.5)

21 (67.7)

 

 Elevated

19 (36.5)

10 (32.3)

 

Postoperative complication, N%

0.001

 No

46 (73.0)

32 (100.0)

 

 Yes

17 (27.0)

0 (0.0)

 

ICU, N%

0.042

 No

53 (84.1)

32 (100.0)

 

 Yes

10 (15.9)

0 (0.0)

 

Stoma, N%

0.198

 No

21 (33.3)

15 (46.9)

 

 Yes

42 (66.7)

17 (53.1)

 

1-year locoregional recurrence, N%

0.660

 No

58 (92.1)

31 (96.9)

 

 Yes

5 (7.9)

1 (3.1)

 

1-y Mortality, N%

0.439

 No

51 (82.3)

29 (90.6)

 

 Yes

11 (17.7)

3 (9.4)

 

1-y with stoma, N%

0.047

 No

46 (73.0)

29 (90.6)

 

 Yes

17 (27.0)

3 (9.4)

 

Postoperative bowel  function (days), median, (IQR)

5.00 (3.00-6.00)

3.00 (2.00-3.00)

< 0.001

 Postoperative hospital stay (days), median, (IQR)

13.00 (10.00-19.00)

8.00 (7.25-11.75)

< 0.001

 Total Hospital stay (days), median, (IQR)

20.00 (16.00-25.00)

15.50 (13.00-18.75)

0.002

 Surgery time (min), median, (IQR)

230.00 (180.00-300.00)

213.00 (188.50-270.00)

0.428

 Intraoperative blood loss (ml), median, (IQR)

100.0 (50.0-200.0)

100.00 (50.00-187.50)

0.209

  1. *Surgery: Immediate Emergency Colorectal Resection;
  2. *Neoadjuvant chemotherapy: Immediate SEMS or Decompressing Stoma followed by Neoadjuvant chemotherapy before Elective Colorectal Resection